24.05.2016
- The US Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) cancer drug, Opdivo, to treat classical Hodgkin Lymphoma (HL). The approval is the eighth for...
About 10 years ago, CHEManager decided to present discussions about logistics as a separate theme. Since then, the terms “chemical logistics” and “pharmaceutical...
04.05.2016
- MilliporeSigma, the former Merck Millipore, has announced plans to expand its state-of-the-art single-use current good manufacturing process (cGMP) facility with the addition of...
22.04.2016
- US drugmaker Merck has gained Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration (FDA) for Keytruda to treat patients with classical Hodgkin lymphoma...
14.04.2016
- With immediate effect, Merck KGaA has appointed Maya Martinez-Davis (46) as global head of oncology for its biopharma business, succeeding Andrew Schiermeier. She will be based in...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
17.02.2016
- Germany’s Merck KGaA has signed a new framework agreement with Israel’s Weizmann Institute of Science, extending their partnership for another three years with the option for...
15.02.2016
- Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...
